Posts

Outspoken ACIP Member Robert Malone Steps Down Amid Vaccine Panel Uncertainty

Dr. Robert Malone, vice chair of the Advisory Committee on Immunization Practices (ACIP) and ally of HHS Secretary Robert F. Kennedy Jr., resigned from the panel after a federal judge ruled that the newly appointed members lacked required expertise. 2 3 The judge blocked ACIP's actions, including changes to the pediatric vaccine schedule like delaying the hepatitis B birth dose, and restored the original schedule. 1 2 5 Malone cited reasons including 'uncompensated labor' and 'incredible hate,' expressed frustration on X by calling for the judge's impeachment, and initially claimed ACIP was disbanded before retracting. 2 3 4 ACIP was reformed by Kennedy last year after dismissing the prior panel for alleged pharmaceutical influence; HHS has not confirmed an appeal of the ruling. 1 2 Sources: 1. https://www.fiercepharma.com/pharma/outspoken-acip-member-steps-down-amid-vaccine-panel-controversy-legal-bulwark 2. https://www.statnews.com/2026/03/24/feder...

Wave Life Sciences' Obesity Drug WVE-007 Shows Strong Early Fat Loss Results, Not 1% Dip

Takeda Announces Leadership Transition with Julie Kim as New CEO Amid Organizational Changes

Recent Pharmaceutical Industry Developments: AbbVie's China Engagement and Biologics Expansion

FDA Approves Denali Therapeutics' Avlayah for Hunter Syndrome, First Treatment for Neurologic Manifestations

Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape

Maze Therapeutics Meets Expectations in Phase 2 HORIZON Trial for APOL1-Mediated Kidney Disease, Positioning to Challenge Vertex

After Tumultuous Year, Sarepta Plots Rebound with Early Data on RNA Therapies

FDA Approves Corcept's Lifyorli for Platinum-Resistant Ovarian Cancer Months Early

FDA Grants Accelerated Approval to Denali's Avlayah for Hunter Syndrome, Defying Rare Disease Rejection Trend

CROSSJECT Appoints Lionel Seltz as Chief Financial Officer

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

Allergan Aesthetics Reinforces Scientific Leadership with 21 Evidence-Based E-Posters at AMWC 2026